Ionctura
Clinical trials sponsored by Ionctura, explained in plain language.
-
New drug IOA-244 aims to boost immune system against advanced cancers
Disease control OngoingThis early-stage study tests a new drug called IOA-244 in about 210 adults with advanced or metastatic cancers, including lung cancer, melanoma, and lymphoma. The main goal is to see if the drug is safe and tolerable, both alone and with other treatments. Researchers also want to…
Phase: PHASE1 • Sponsor: iOnctura • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
New drug shows promise in fighting rare eye cancer
Disease control OngoingThis study tests a new drug called roginolisib in adults with advanced uveal melanoma, a rare eye cancer that has spread. About 85 participants will receive either roginolisib or standard treatment to see if the drug helps them live longer and improves their quality of life. The …
Phase: PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated May 26, 2026 10:26 UTC
-
New hope for tough lung cancers: Triple-Drug combo trial launches
Disease control OngoingThis study tests a new drug combination (roginolisib plus dostarlimab, with or without docetaxel) in adults with advanced non-squamous lung cancer that worsened after standard treatments. The goal is to see if the combination can safely reduce certain immune cells (Tregs) and con…
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated May 22, 2026 13:52 UTC